PROCESS FOR INDUSTRIALLY PREPARING STANDARDIZED EXTREMELY PURE CONCENTRATEOF HUMAN VON WILLEBRAND FACTOR, SUITABLE FOR THERAPEUTICAL APPLICATION

• 1. 获得冯维勒布兰德氏因子浓缩物或因子Ⅷ/冯维勒布兰德氏因子复合物的方法和它们的用途 [P] . 中国专利： CN101480490B . 2013.05.29
• 2. 获得冯维勒布兰德氏因子浓缩物或因子Ⅷ/冯维勒布兰德氏因子复合物的方法和它们的用途 [P] . 中国专利： CN101480490A . 2009-07-15
• 3. PROCESS FOR INDUSTRIALLY PREPARING STANDARDIZED EXTREMELY PURE CONCENTRATEOF HUMAN VON WILLEBRAND FACTOR, SUITABLE FOR THERAPEUTICAL APPLICATION [P] . CS56892A3 . 1992-09-16

  机译： 工业上制备人冯·威勒伯兰德因子的极度纯净浓缩物的方法，适用于治疗性应用

• 4. PROCESS FOR PREPARING A STANDARDIZED EXTREMELY PURE CONCENTRATE OF HUMAN VON WILLEBRAND FACTOR WITH A HIGH PROPORTION OF HIGH-MOLECULAR MULTIMERS AND THE CONCENTRATE OBTAINED IN SUCH A MANNER [P] . CZ283633B6 . 1998-05-13

  机译： 制备比例很高的高分子量多聚体人均冯威勒布兰德标准超纯浓缩物的方法

• 5. PROCESS FOR THE INDUSTRIAL-SCALE PREPARATION OF A HIGHLY PURE STANDARDIZED HUMAN VON WILLEBRAND FACTOR CONCENTRATE APPROPRIATE FOR THERAPEUTIC USE [P] . CA2062340C . 2000-05-09

  机译： 适用于治疗用途的高纯度标准人冯·威勒布兰德因子浓缩物的工业规模制备方法

• 1. Surface Dependent Expression of Platelet GPIb Binding Domain Within Human von Willebrand Factor Studied by Atomic Force Microscopy [C] . Inkyung Kang, Madhusudan Raghavachari, Roger E. Marchant Annual meeting of the Society For Biomaterials . 2002
• 2. Coarse Grain Molecular Model Development and Implementation for Describing von Willebrand Factor Behavior in Human Blood Flow [D] . Wei, Wei. 2017
• 3. Standardization of von Willebrand factor propeptide: value assignment to the WHO 6th IS Factor VIII/von Willebrand factor plasma (07/316) [O] . A. R. Hubbard, M. Hamill, H. C. J. Eikenboom, -1
• 4. Standardization of von Willebrand factor propeptide: value assignment to the WHO 6th IS Factor VIII/von Willebrand factor, plasma (07/316) [O] . A. R. HUBBARD, M. HAMILL, H. C. J. EIKENBOOM, 2012
• 5. Standardized UXO Technology Demonstration Site Open Field Scoring Recording Number 231 (Human Factors Applications, Inc.) [R] . Overbay, L. , Robitaille, G. 2005

• 1. von Willebrand factor antigen as a therapeutic target of portal hypertension in cirrhosis [J] . Georgios N Kalambokis ,Gerasimos Baltayiannis ,Dimitrios Christodoulou . 世界胃肠病学杂志：英文版 . 2016,第19期
• 2. STAGO全自动血凝仪在人凝血因子活性测定上的应用 [C] . Liu Zhao-yang ,刘朝阳 ,Cheng Peng-fei . 2015中国生物制品年会暨第十五次全国生物制品学术研讨会 . 2015
• 3. 视觉显著性算法在智能工业机器人上的应用 [A] . 阎一鸣 . 2020